ASCENTAGE PHARMA GROUP INTERNATIONAL
AAPG · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $38,318 | $8,705 | $7,902 | $7,027 |
| - Cash | $1,237 | $1,069 | $1,476 | $1,707 |
| + Debt | $1,668 | $1,796 | $1,793 | $1,084 |
| Enterprise Value | $38,749 | $9,432 | $8,219 | $6,405 |
| Revenue | $981 | $222 | $210 | $28 |
| % Growth | 341.8% | 5.9% | 651.4% | – |
| Gross Profit | $952 | $191 | $188 | $25 |
| % Margin | 97% | 86.2% | 89.5% | 88.1% |
| EBITDA | -$238 | -$744 | -$787 | -$798 |
| % Margin | -24.2% | -335% | -375.3% | -2,860.4% |
| Net Income | -$405 | -$926 | -$883 | -$782 |
| % Margin | -41.3% | -417% | -421% | -2,803.4% |
| EPS Diluted | -1.34 | -13.12 | -13.4 | -12.28 |
| % Growth | 89.8% | 2.1% | -9.1% | – |
| Operating Cash Flow | -$111 | -$726 | -$654 | -$605 |
| Capital Expenditures | -$24 | -$57 | -$237 | -$437 |
| Free Cash Flow | -$136 | -$783 | -$891 | -$1,041 |